Tanuxiciclib
Tanuxiciclib is a cyclin dependent kinase (CDK) inhibitor[1].
Product Specifications
CAS Number
[1983983-64-7]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tanuxiciclib.html
Purity
98.0
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC1=C(C2=CC=C(O)C(C3=CC(C)=NC(N)=N3)=N2)C=CN=C1N
Molecular Formula
C15H13FN6O
Molecular Weight
312.30
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 35, No. 4, 2021.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1374058-01 0.02 mg (E-Coli)
Recombinant Deinagkistrodon acutus Agglucetin subunit alpha-1
Ask
View Details 
MBS1374058-02 0.1 mg (E-Coli)
Recombinant Deinagkistrodon acutus Agglucetin subunit alpha-1
Ask
View Details MBS1374058-03 0.02 mg (Yeast)
Recombinant Deinagkistrodon acutus Agglucetin subunit alpha-1
Ask
View Details MBS1374058-04 0.1 mg (Yeast)
Recombinant Deinagkistrodon acutus Agglucetin subunit alpha-1
Ask
View Details MBS1374058-05 0.02 mg (Baculovirus)
Recombinant Deinagkistrodon acutus Agglucetin subunit alpha-1
Ask
View Details